{
    "body_text": [
        {
            "endOffset": 24838,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The intent of this document is to provide a standardized case definition and guidelines to improve reliability and comparability of data collected in clinical trials and observational studies and to provide a standardized framework for consistently monitoring the safety of vaccines currently recommended during pregnancy or available to women of reproductive age.",
            "startOffset": 24474,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 57871,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Events that meet the case definition should be classified according to the levels of diagnostic certainty as specified in the case definition.",
            "startOffset": 57729,
            "title": "Data analysis"
        },
        {
            "endOffset": 32552,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Additionally, it is important to differentiate congenital microcephaly due to a known cause from congenital microcephaly without clear aetiology.",
            "startOffset": 32407,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 64595,
            "parents": [],
            "secId": "s0100",
            "sentence": "Specifically, the findings and conclusions in this paper are those of the authors and do not necessarily represent the views of their respective institutions.",
            "startOffset": 64437,
            "title": "Disclaimer"
        },
        {
            "endOffset": 47978,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0050",
            "sentence": "These guidelines represent a desirable standard for the collection of data on availability following maternal immunisation to allow for comparability of data, and are recommended as an addition to data collected for the specific study question and setting.",
            "startOffset": 47722,
            "title": "Data collection"
        },
        {
            "endOffset": 24017,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The authors of the Congenital Anomalies GAIA-Brighton Case Definition reviewed studies evaluating associations between vaccination in pregnancy, including both vaccines routinely recommended during pregnancy (influenza and Tdap) and vaccinations inadvertently administered during pregnancy (live virus vaccines, Human Papillomavirus [HPV], and meningococcal vaccines), and found no increased risk of congenital anomalies, including congenital microcephaly [53].",
            "startOffset": 23556,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 55788,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Objective clinical evidence supporting classification of the event as \u201cserious\u201d.9",
            "startOffset": 55297,
            "title": "The adverse event"
        },
        {
            "endOffset": 36112,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "General recommendations for optimal HC measurement in a fetus with normal intracranial anatomy include [59]:",
            "startOffset": 36004,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 29381,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "The case definition has been formulated such that the Level One definition is highly specific for the condition.",
            "startOffset": 29269,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 17568,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Congenital microcephaly may occur as an isolated structural birth defect or in combination with other birth defects.",
            "startOffset": 17452,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39717,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Measured between 24 and 36 h after birth or end of pregnancy.",
            "startOffset": 39656,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 49338,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0050",
            "sentence": "Furthermore, these guidelines are also called to serve as a standard guidance in the case definition of congenital microcephaly in the context of observational studies conducted in pregnant women.",
            "startOffset": 49142,
            "title": "Data collection"
        },
        {
            "endOffset": 48719,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0050",
            "sentence": "Guidelines 1\u201342 below have been developed to address data elements for the collection of adverse event information as specified in general drug safety guidelines by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use [66], and the form for reporting of drug adverse events by the Council for International Organizations of Medical Sciences [67].",
            "startOffset": 48304,
            "title": "Data collection"
        },
        {
            "endOffset": 61796,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "Data on possible congenital microcephaly events should be presented in accordance with data collection guidelines 1\u201323 and data analysis guidelines 30\u201334.",
            "startOffset": 61642,
            "title": "Data presentation"
        },
        {
            "endOffset": 20891,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Prevalence of microcephaly in the 15 states of Brazil with laboratory-confirmed Zika virus transmission was 2.8 cases per 10,000 live births, which was significantly higher than in the four Brazilian states without Zika virus transmission (prevalence 0.6 cases per 10,000 live births).",
            "startOffset": 20606,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 53867,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Concurrent signs, symptoms, and diseases.",
            "startOffset": 53826,
            "title": "The adverse event"
        },
        {
            "endOffset": 23040,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Multiple studies have evaluated associations between both recommended and inadvertent vaccination in pregnancy and subsequent diagnosis of congenital anomalies in the offspring [26\u201351].",
            "startOffset": 22855,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 32744,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Again, consistent with the Brighton Case Definition for congenital anomalies, we recommend altering the analysis plan if a study includes congenital microcephaly cases with well-known causes.",
            "startOffset": 32553,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 52886,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Route and method of administration (e.g., intramuscular, intradermal, subcutaneous, and needle-free (including type and size), other injection devices).",
            "startOffset": 52734,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 33884,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Depending on when the diagnosis is made, congenital microcephaly is stratified into the following categories:",
            "startOffset": 33775,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 26068,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "To guide the decision-making for the case definition and guidelines, a literature search was performed using Medline, Embase and Scopus, including the terms (vaccin\u2217 and pregnan\u2217).",
            "startOffset": 25888,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26071,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "ti.",
            "startOffset": 26068,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 42249,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Diagnosis of congenital microcephaly based on physical inspection without HC measurement",
            "startOffset": 42161,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 26148,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "ti.",
            "startOffset": 26145,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26500,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "mp.",
            "startOffset": 26497,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 18385,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "We have focused on congenital microcephaly for this case definition and will not address acquired microcephaly.",
            "startOffset": 18274,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 47106,
            "parents": [],
            "secId": "s0045",
            "sentence": "It was the consensus of the Brighton Collaboration Congenital Microcephaly Working Group to recommend the following guidelines to enable meaningful and standardized collection, analysis, and presentation of information about congenital microcephaly.",
            "startOffset": 46857,
            "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
        },
        {
            "endOffset": 26334,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "OR ((vaccine\u2217 or vaccination\u2217) and pregnant\u2217).",
            "startOffset": 26288,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 22855,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "More than 1100 clinical syndromes associated with the clinical sign, \u201cmicrocephaly,\u201d were recorded in the Online Mendelian Inheritance in Man (OMIM http://www.ncbi.nlm.nih.gov/omim) as of June 2016 [25].",
            "startOffset": 22652,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 55962,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Exposures other than maternal immunisation during pregnancy (e.g., maternal medications, infections, environmental) considered potentially relevant to the reported event.",
            "startOffset": 55792,
            "title": "The adverse event"
        },
        {
            "endOffset": 39204,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Because prenatally diagnosed congenital microcephaly relies on the use of ultrasound technology, it is not feasible to diagnose this condition in areas without access to ultrasound machines.A.",
            "startOffset": 38421,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 25618,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Following the process described in the overview paper [54] as well as on the Brighton Collaboration Website http://www.brightoncollaboration.org/internet/en/index/process.html, the Brighton Collaboration Congenital Microcephaly Working Group was formed in 2016 and included members with background in clinical medicine, paediatrics, neonatology, neurology, vaccinology, research, public health and industry.",
            "startOffset": 25211,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 27463,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Findings from the literature search were for the most part single case reports, in which the terminology was very inconsistent with no standard case definitions.",
            "startOffset": 27302,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26186,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "AND (microcephaly or microencephaly).",
            "startOffset": 26149,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 48941,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0050",
            "sentence": "These data elements include an identifiable reporter and patient, one or more prior immunisations, and a detailed description of the adverse event, in this case, of congenital microcephaly following maternal immunisation.",
            "startOffset": 48720,
            "title": "Data collection"
        },
        {
            "endOffset": 35242,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Marked in 0.1 cm increments",
            "startOffset": 35215,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 18922,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Terms such as microcephaly or microencephalia are used interchangeably when referring to reduction in brain mass, rather than decreased head circumference.",
            "startOffset": 18767,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 18564,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The term \u201crelative microcephaly\u201d is used when an infant is below standard weight and length for gestational age and sex with a proportionally small head circumference measurement.",
            "startOffset": 18385,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 28177,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "If not detected prenatally, as is often the case in low resource settings, congenital microcephaly is most commonly diagnosed postnatally, in the first few days following birth or during autopsy of stillbirths or spontaneous or therapeutic abortions.",
            "startOffset": 27927,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 59979,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "If more than one measurement of a particular criterion is taken and recorded, the value corresponding to the greatest magnitude of the adverse experience could be used as the basis for analysis.",
            "startOffset": 59785,
            "title": "Data analysis"
        },
        {
            "endOffset": 49878,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0055",
            "sentence": "Name and contact information of the investigator responsible for the subject, as applicable.",
            "startOffset": 49786,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 50812,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                },
                {
                    "id": "s0060",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0070",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 50706,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 52111,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 52005,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 17452,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Severe microcephaly is defined as head circumference more than 3 SDs below the mean for age and sex [4\u20137].",
            "startOffset": 17346,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26189,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "mp.",
            "startOffset": 26186,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26895,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Nine articles with potentially relevant material were reviewed in more detail, in order to identify studies using case definitions or, in their absence, providing clinical descriptions of the case material.",
            "startOffset": 26689,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 47187,
            "parents": [],
            "secId": "s0045",
            "sentence": "However, implementation of all guidelines might not be possible in all settings.",
            "startOffset": 47107,
            "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
        },
        {
            "endOffset": 29268,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "The number of symptoms and/or signs that will be documented for each case may vary considerably.",
            "startOffset": 29172,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 40857,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "HC 2 SD below mean or <3 percentile according to GA and gender, using appropriate standardized reference charts for the population (e.g., WHO growth reference charts if GA \u2a7e37 weeks and Intergrowth-21st reference charts for GA 24\u201336 weeks)",
            "startOffset": 40618,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 64129,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "Use of this case definition for congenital microcephaly, in the abstract or methods section of a publication.13",
            "startOffset": 63850,
            "title": "Data presentation"
        },
        {
            "endOffset": 52370,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Description of vaccine(s) (name of vaccine, manufacturer, lot number, dose [e.g., 0.25 mL, 0.5 mL, etc.], and expiration date) and number of dose if part of a series of immunisations against the same disease).",
            "startOffset": 52161,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 40205,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "HC 2 SD below mean or <3 percentile according to GA and gender, using appropriate standardized reference charts for the population (e.g., WHO growth reference charts if GA \u2a7e37 weeks and Intergrowth-21st reference charts for GA 24\u201336 weeks)",
            "startOffset": 39966,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 19408,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "A variety of estimates of the incidence of congenital microcephaly have been published in the literature, reflecting the heterogeneous definitions and methods used.",
            "startOffset": 19244,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 54043,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Method of measurement (e.g., type of measuring tape, method of measurement, etc.);",
            "startOffset": 53961,
            "title": "The adverse event"
        },
        {
            "endOffset": 26109,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "AND (microcephaly or microencephaly).",
            "startOffset": 26072,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35133,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Head Circumference Tape Measure Checklist:",
            "startOffset": 35091,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 27195,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "This review resulted in a detailed summary of 27 articles, including information on the study type, the vaccine, the diagnostic criteria or case definition put forth, the time interval since time of immunisation, and any other symptoms.",
            "startOffset": 26959,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 42441,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "B. Prenatally diagnosed Congenital Microcephaly Case Definition",
            "startOffset": 42378,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 39869,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Level 2A of diagnostic certainty",
            "startOffset": 39837,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 59147,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Not a case of congenital microcephaly11",
            "startOffset": 58866,
            "title": "Data analysis"
        },
        {
            "endOffset": 43547,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "HC 2 SD below mean or <3 percentile according to fetal ultrasound (US) examination using appropriate standardized reference charts according to GA and gender for the population (e.g., WHO growth reference charts if GA \u2a7e37 weeks and Intergrowth-21st reference charts for GA 24\u201336 weeks)",
            "startOffset": 43262,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 17345,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Congenital microcephaly can be diagnosed either postnatally or prenatally and is usually defined by the measurement of occipital-frontal circumference (head circumference) that is more than 2 standard deviations (SDs) below the mean for age and sex or less than the 3rd percentile for age and sex [1\u20133].",
            "startOffset": 17042,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 19843,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Incidence rates of congenital microcephaly have been estimated to vary between 0.58 and 1.87 per 10,000 live births in studies conducted in the United States and Europe [9].",
            "startOffset": 19670,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 34198,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "In order to apply the case definition of postnatally diagnosed congenital microcephaly, it is necessary to first obtain an accurate HC measurement using a flexible, non-stretchable measuring tape.",
            "startOffset": 34002,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 27587,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "An inventory comprising 3 relevant case definitions of congenital microcephaly was made available to working group members.",
            "startOffset": 27464,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 41529,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "HC 2 SD below mean or <3 percentile according to GA and gender, using appropriate standardized reference charts for the population (e.g., WHO growth reference charts if GA \u2a7e37 weeks and Intergrowth-21st reference charts for GA 24\u201336 weeks)",
            "startOffset": 41290,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 35737,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "In order to apply the case definition of prenatally diagnosed congenital microcephaly, it is necessary to obtain an accurate HC measurements via prenatal ultrasound (US) scan by a sonographer or a health professional trained in sonography.",
            "startOffset": 35498,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 30675,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "However laboratory data (e.g., genetic test results) should be included as supportive data as many known causes of congenital microcephaly can be diagnosed through laboratory studies.",
            "startOffset": 30492,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 49783,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0055",
            "sentence": "Name and contact information of person reporting4 and/or diagnosing congenital microcephaly as specified by country-specific data protection law.",
            "startOffset": 49500,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 41814,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Live birth, stillbirth, or spontaneous or therapeutic abortion",
            "startOffset": 41752,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 17766,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Microcephaly has been associated with intellectual disability [8].",
            "startOffset": 17700,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 44325,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "HC 2 SD below mean or <3 percentile according to fetal US scan using appropriate standardized reference charts according to GA and gender for the population (e.g., WHO growth reference charts if GA \u2a7e37 weeks and Intergrowth-21st reference charts for GA 24\u201336 weeks) with femur length and abdominal circumference concordant with GA assessment",
            "startOffset": 43984,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 28438,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "We have incorporated this additional level of classification into our case definition.",
            "startOffset": 28352,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 42611,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Fetus of at least 24 weeks GA based on certain LMP with confirmatory 1st trimester or 2nd trimester US scan IUI, or embryo transfer date",
            "startOffset": 42475,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 31353,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Therefore, to avoid selection bias, a restrictive time interval from immunisation during pregnancy to onset of congenital microcephaly should not be an integral part of such a definition.",
            "startOffset": 31166,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 42092,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Level 4 of diagnostic certainty",
            "startOffset": 42061,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 40894,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Measured within the first 24 h \u00a7",
            "startOffset": 40862,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 45337,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Level 3B of diagnostic certainty",
            "startOffset": 45305,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 17042,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Congenital microcephaly, also referred to as primary microcephaly due to its presence in utero or at birth, is a descriptive term for a structural defect in which a fetus or infant\u2019s head (cranium) circumference is smaller than expected when compared to other fetuses or infants of the same gestational age, sex and ethnic background.",
            "startOffset": 16708,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 52730,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "The anatomical sites (including left or right side) of all immunisations (e.g., vaccine A in proximal left lateral thigh, vaccine B in left deltoid).",
            "startOffset": 52581,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 31893,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "In order to avoid selecting against such cases, the Brighton Collaboration case definition avoids setting arbitrary time frames.",
            "startOffset": 31765,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35214,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "wide",
            "startOffset": 35210,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 20605,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "An increase in the reported prevalence of microcephaly was noted in some areas of Brazil during 2015 where there was confirmed Zika virus transmission [13].",
            "startOffset": 20449,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 33038,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0025",
            "sentence": "As mentioned in the overview paper, the case definition is accompanied by guidelines, which are structured according to the steps of conducting a clinical trial or observational study, i.e., data collection, analysis and presentation.",
            "startOffset": 32804,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 49988,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0055",
            "sentence": "Relation to the patient (e.g., immunizer [clinician, nurse], family member [indicate relationship], other).",
            "startOffset": 49881,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 43181,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Level 1B of diagnostic certainty",
            "startOffset": 43149,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 62016,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "Terms to describe congenital microcephaly such as \u201clow-grade\u201d, \u201cmild\u201d, \u201cmoderate\u201d, \u201chigh\u201d, \u201csevere\u201d or \u201csignificant\u201d are highly subjective, prone to wide interpretation, and should be avoided, unless clearly defined.",
            "startOffset": 61800,
            "title": "Data presentation"
        },
        {
            "endOffset": 26281,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "AND (immunisation\u2217 and pregnan\u2217).",
            "startOffset": 26248,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 19670,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Studies evaluating population level prevalence are limited as most available reports are based on small case numbers and focus on discrete populations such as individuals with cerebral palsy or musculoskeletal defects, making these studies poorly generalizable.",
            "startOffset": 19409,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 41750,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Level 3B of diagnostic certainty",
            "startOffset": 41718,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 22363,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In the largest published cohort of infants with microcephaly, genetic causes accounted for approximately one third of cases followed by perinatal brain injury and postnatal brain injury [22].",
            "startOffset": 22172,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 60242,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "The distribution of data (as numerator and denominator data) could be analysed in predefined increments (e.g., measured values, times), where applicable.",
            "startOffset": 60089,
            "title": "Data analysis"
        },
        {
            "endOffset": 32406,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "However, we believe it is important to record the time interval between maternal immunisation at any time during pregnancy and the diagnosis of congenital microcephaly in order to best evaluate the association between maternal vaccination and congenital microcephaly.",
            "startOffset": 32139,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 43054,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Confirmation of microcephaly (i.e., HC 2 SD below mean or <3 percentile) in fetus by at least one additional US scan after 24 weeks and at least one week after first US",
            "startOffset": 42886,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 63849,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "Whether the date of onset4 and/or the date of first observation4 and/or the date of diagnosis 5 was used for analysis; and",
            "startOffset": 63727,
            "title": "Data presentation"
        },
        {
            "endOffset": 48111,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0050",
            "sentence": "The guidelines are not intended to guide the primary reporting of congenital microcephaly to a surveillance system or study monitor.",
            "startOffset": 47979,
            "title": "Data collection"
        },
        {
            "endOffset": 26497,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "AND (microcephaly or microencephaly).",
            "startOffset": 26460,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 63638,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "The instrument of data collection (e.g., standardized questionnaire, diary card, report form);",
            "startOffset": 63544,
            "title": "Data presentation"
        },
        {
            "endOffset": 47454,
            "parents": [],
            "secId": "s0045",
            "sentence": "The availability of information may vary depending upon resources, geographical region, and whether the source of information is a prospective clinical trial, a post-marketing surveillance or epidemiological study, or an individual report of congenital microcephaly.",
            "startOffset": 47188,
            "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
        },
        {
            "endOffset": 17699,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Physiologically, congenital microcephaly is a disorder of reduced brain size and volume resulting from abnormal fetal development.",
            "startOffset": 17569,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 32138,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Consistent with the Brighton Case Definition for congenital anomalies [53], we note that the first trimester of pregnancy is considered the most critical period for teratogen exposure with regards to subsequent effects on fetal development [55].",
            "startOffset": 31893,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 31764,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "In some settings it may be impossible to obtain a clear timeline of the event or diagnosis either prenatally or at birth, particularly in less developed or rural settings.",
            "startOffset": 31593,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 58556,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Specify postnatally or prenatally diagnosed congenital microcephaly",
            "startOffset": 58489,
            "title": "Data analysis"
        },
        {
            "endOffset": 29756,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "In this way it is hoped that all possible cases of congenital microcephaly can be captured.",
            "startOffset": 29665,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 29664,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "As maximum specificity normally implies a loss of sensitivity, additional diagnostic levels have been included in the definition, offering a stepwise increase of sensitivity from Level One down to Level Four or Five, while retaining an acceptable level of specificity at all levels.",
            "startOffset": 29382,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 48304,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0050",
            "sentence": "Investigators developing a data collection tool based on these data collection guidelines also need to refer to the criteria in the case definition, which are not repeated in these guidelines.",
            "startOffset": 48112,
            "title": "Data collection"
        },
        {
            "endOffset": 63285,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "The trial profile, indicating participant flow during a study including drop-outs and withdrawals to indicate the size and nature of the respective groups under investigation;",
            "startOffset": 63110,
            "title": "Data presentation"
        },
        {
            "endOffset": 53291,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Clinical description of signs and symptoms of congenital microcephaly, and if there was medical confirmation of the event (i.e., patient seen by physician).",
            "startOffset": 53135,
            "title": "The adverse event"
        },
        {
            "endOffset": 34947,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Please note that the occiput may not always be easily recognizable, particularly if there is significant molding of the infant\u2019s head.",
            "startOffset": 34813,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 46772,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "HC at birth or autopsy is in the normal range using appropriate standardized reference charts according to GA and gender for the population, which means that this is NOT a case of prenatally diagnosed congenital microcephaly",
            "startOffset": 46548,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 26287,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "sh,kw.",
            "startOffset": 26281,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 28888,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "It needs to be emphasised that the grading of definition levels is used to determine diagnostic certainty, not the clinical severity of an event.",
            "startOffset": 28743,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 24159,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "There is no uniformly accepted definition of congenital microcephaly as an adverse event in a fetus or infant following maternal immunisation.",
            "startOffset": 24017,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39266,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Postnatally diagnosed Congenital Microcephaly Case Definition",
            "startOffset": 39205,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 53822,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Date/time of first observation5 of congenital microcephaly and diagnostic confirmation,6 and final outcome.7",
            "startOffset": 53295,
            "title": "The adverse event"
        },
        {
            "endOffset": 39407,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Live birth, stillbirth, or spontaneous or therapeutic abortion of at least 24 weeks of Gestational Age (GA)\u223c",
            "startOffset": 39299,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 53109,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "For all cases at any level of diagnostic certainty and for reported events with insufficient evidence, the criteria fulfilled to meet the case definition should be recorded.",
            "startOffset": 52936,
            "title": "The adverse event"
        },
        {
            "endOffset": 57979,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Events that do not meet the case definition should be classified in the additional categories for analysis.",
            "startOffset": 57872,
            "title": "Data analysis"
        },
        {
            "endOffset": 37964,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "The standards are very similar to those of the WHO MGRS, are readily available online and are endorsed by the International Society for Ultrasonography in Obstetrics and Gynecology [60,63].",
            "startOffset": 37775,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 40489,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "\u223cGA assessed based on certain LMP with confirmatory 1st trimester or 2nd trimester US scan, IUI, or embryo transfer date",
            "startOffset": 40369,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 58235,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Event classification in 5 categories10",
            "startOffset": 57979,
            "title": "Data analysis"
        },
        {
            "endOffset": 58738,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Event does not meet case definition",
            "startOffset": 58703,
            "title": "Data analysis"
        },
        {
            "endOffset": 36004,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Using the US machine\u2019s ellipse facility, the lines of the ellipse should be placed on the outer border of the fetal skull in order to obtain the HC measurement [59].",
            "startOffset": 35839,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 58489,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Level 2: Criteria as specified in the congenital microcephaly case definition",
            "startOffset": 58412,
            "title": "Data analysis"
        },
        {
            "endOffset": 39297,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Level 1 of diagnostic certainty",
            "startOffset": 39266,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 41083,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "\u223cGA assessed based on uncertain LMP with 2nd trimester US scan",
            "startOffset": 41021,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 58703,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Specify postnatally or prenatally diagnosed congenital microcephaly",
            "startOffset": 58636,
            "title": "Data analysis"
        },
        {
            "endOffset": 36737,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Accurate gestational age determination is vital when determining congenital microcephaly based on prenatal ultrasound scan.",
            "startOffset": 36614,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 61040,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "These guidelines represent a desirable standard for the presentation and publication of data on congenital microcephaly following maternal immunisation to allow for comparability of data, and are recommended as an addition to data presented for the specific study question and setting.",
            "startOffset": 60755,
            "title": "Data presentation"
        },
        {
            "endOffset": 28688,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "The diagnostic levels must not be misunderstood as reflecting different grades of clinical severity.",
            "startOffset": 28588,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 34812,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "To measure the HC, securely wrap the tape measure around the widest possible circumference of the infant\u2019s head (typically, 1\u20132 finger-widths above the eyebrow (supraorbital ridges) on the forehead, above the ears, to the most prominent part of the back of the head (occiput) (Fig. 1).",
            "startOffset": 34527,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 57728,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Reported events should be classified in one of the following five categories including the four (postnatally diagnosed congenital microcephaly) or five (prenatally diagnosed microcephaly) levels of diagnostic certainty.",
            "startOffset": 57509,
            "title": "Data analysis"
        },
        {
            "endOffset": 26247,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "sh,kw.",
            "startOffset": 26241,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 43149,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Confirmation of microcephaly by HC measurement with standard tape measure at birth or autopsy",
            "startOffset": 43056,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 46003,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Level 4 of diagnostic certainty",
            "startOffset": 45972,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 46543,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "HC 2 SD below mean or <3 percentile according to fetal US scan using appropriate standardized reference charts according to GA and gender for the population (e.g., WHO growth reference charts if GA \u2a7e37 weeks and Intergrowth-21st reference charts for GA 24\u201336 weeks)",
            "startOffset": 46278,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 58262,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Event meets case definition",
            "startOffset": 58235,
            "title": "Data analysis"
        },
        {
            "endOffset": 60285,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Increments specified above should be used.",
            "startOffset": 60243,
            "title": "Data analysis"
        },
        {
            "endOffset": 20237,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "There are very limited data on the prevalence of congenital microcephaly in low and middle-income countries (LMIC).",
            "startOffset": 20122,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 51973,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                },
                {
                    "id": "s0060",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0070",
            "sentence": "Maternal immunisation history (i.e., previous immunisations and any adverse event following immunisation (AEFI)), in particular occurrence of congenital microcephaly in a prior pregnancy following previous maternal immunisation.",
            "startOffset": 51745,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 63543,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "Comparison group(s), if used for analysis;",
            "startOffset": 63501,
            "title": "Data presentation"
        },
        {
            "endOffset": 26241,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "OR (microcephaly or microencephaly or small head\u2217).",
            "startOffset": 26190,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26381,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "mp.",
            "startOffset": 26378,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 42881,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "HC 2 SD below mean or <3 percentile according to fetal US scan using appropriate standardized reference charts according to GA and gender for the population (e.g., WHO growth reference charts if GA \u2a7e37 weeks and Intergrowth-21st reference charts for GA 24\u201336 weeks)",
            "startOffset": 42616,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 58342,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Level 1: Criteria as specified in the congenital microcephaly case definition",
            "startOffset": 58265,
            "title": "Data analysis"
        },
        {
            "endOffset": 63726,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "Whether the day of immunisation was considered \u201cday one\u201d or \u201cday zero\u201d in the analysis;",
            "startOffset": 63639,
            "title": "Data presentation"
        },
        {
            "endOffset": 44627,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Level 3A of diagnostic certainty",
            "startOffset": 44595,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 58409,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Specify postnatally or prenatally diagnosed congenital microcephaly",
            "startOffset": 58342,
            "title": "Data analysis"
        },
        {
            "endOffset": 19244,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Thus, despite congenital microcephaly typically being associated with a small head circumference, in the case of hydrocephalus, since there can be reduced brain mass with a normal or enlarged head circumference due to enlarged ventricles from excess central nervous system fluid it would still be considered microcephaly.",
            "startOffset": 18923,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 63350,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "The type of surveillance (e.g., passive or active surveillance);",
            "startOffset": 63286,
            "title": "Data presentation"
        },
        {
            "endOffset": 39837,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "\u223cGA assessed based on certain LMP with confirmatory 1st trimester or 2nd trimester US scan, IUI, or embryo transfer date",
            "startOffset": 39717,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 59781,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "The interval between immunisation and reported congenital microcephaly could be defined as the date/time of immunisation (with regards to gestational age) to the date/time of clinical recognition12 of the first signs consistent with the definition.",
            "startOffset": 59326,
            "title": "Data analysis"
        },
        {
            "endOffset": 22416,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Approximately 40% of cases are of unknown aetiology.",
            "startOffset": 22364,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26378,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "AND (microcephaly or microencephaly).",
            "startOffset": 26341,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 58863,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Reported congenital microcephaly with insufficient evidence to meet the case definition9",
            "startOffset": 58775,
            "title": "Data analysis"
        },
        {
            "endOffset": 31483,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Instead, where feasible, details of this interval should be assessed and reported as described in the data collection guidelines.",
            "startOffset": 31354,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 43257,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Fetus of at least 24 weeks GA based on uncertain LMP with 2nd trimester US",
            "startOffset": 43183,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 27807,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "The timing of clinical recognition of congenital microcephaly varies by setting.",
            "startOffset": 27727,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 31165,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "We postulate that a definition designed to be a suitable tool for testing causal relationships requires ascertainment of the outcome (e.g., congenital microcephaly) independent from the exposure (e.g., immunisations).",
            "startOffset": 30948,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 42061,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Case meets criteria for microcephaly using a validated algorithm: 1 inpatient diagnosis OR 2 outpatient diagnoses OR 1 outpatient diagnosis AND death in first year using the following diagnostic codes ICD-9-CM code 742.1 or ICD-10-CM code Q02",
            "startOffset": 41819,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 42473,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Level 1A of diagnostic certainty",
            "startOffset": 42441,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 47704,
            "parents": [],
            "secId": "s0045",
            "sentence": "Also, as explained in more detail in the overview paper in this volume, these guidelines have been developed for guidance only by this working group and are not to be considered a mandatory requirement for data collection, analysis, or presentation.",
            "startOffset": 47455,
            "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
        },
        {
            "endOffset": 28587,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Within the definition context, we have assigned levels of diagnostic certainty to both postnatally and prenatally diagnosed congenital microcephaly.",
            "startOffset": 28439,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 41285,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Live birth, stillbirth, or spontaneous or therapeutic abortion of at least 24 weeks of GA\u223c",
            "startOffset": 41195,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 52157,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Date and time of maternal immunisation(s).",
            "startOffset": 52115,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 21192,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In this review covering a period from 2012 to 2015, reported prevalence rates among 16,208 infants ranged from 2.1 to 8.0% based on the different criteria for congenital microcephaly used.",
            "startOffset": 21004,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 43846,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Level 2 of diagnostic certainty",
            "startOffset": 43815,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 58772,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Additional categories for analysis",
            "startOffset": 58738,
            "title": "Data analysis"
        },
        {
            "endOffset": 33446,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0030",
            "sentence": "Similar to all Brighton Collaboration case definitions and guidelines, review of the definition with its guidelines is planned on a regular basis (i.e., every three to five years) or more often if needed.",
            "startOffset": 33242,
            "title": "Periodic review"
        },
        {
            "endOffset": 26456,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "OR (maternal vaccin\u2217 or maternal immunisation\u2217 or maternal immunisation\u2217).",
            "startOffset": 26382,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 51423,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                },
                {
                    "id": "s0060",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0070",
            "sentence": "Specific focus should be on maternal medical conditions associated with increased risk for having an infant with congenital microcephaly (e.g., anorexia nervosa).",
            "startOffset": 51261,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 38168,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Given the prevalence of Hadlock growth measurements in ultrasonography software, using the head circumference guidelines from SMFM may also be acceptable for prenatally diagnosed congenital microcephaly.",
            "startOffset": 37965,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 39651,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "HC 2 SD below mean or <3 percentile according to GA and gender, using appropriate standardized reference charts for the population (e.g., WHO growth reference charts if GA \u2a7e37 weeks and Intergrowth-21st reference charts for GA 24\u201336 weeks)",
            "startOffset": 39412,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 25888,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The composition of the working and reference group as well as results of the web-based survey completed by the reference group with subsequent discussions in the working group can be viewed at: http://www.brightoncollaboration.org/internet/en/index/working_groups.html.",
            "startOffset": 25619,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 21392,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "It should be noted that in addition to microcephaly, Zika virus infection has been associated with other neurologic and brain abnormalities, which can be found in the absence of microcephaly [15\u201320].",
            "startOffset": 21193,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 22017,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Table 1 is a reproduced table which provides an extensive list of genetic disorders including metabolic disorders, perinatal brain injury due to maternal disease or teratogen exposure (including in utero drug or toxin exposure and infectious agents such as toxoplasmosis, rubella, cytomegalovirus, Herpes simplex, syphilis, parvovirus B19, and varicella [TORCH infections]) during pregnancy [22].",
            "startOffset": 21621,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35498,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "It is recommended to record the actual measurement of the head circumference in addition to percentile.",
            "startOffset": 35395,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 43720,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Confirmation of microcephaly (i.e., HC 2 SD below mean or <3 percentile) in fetus by at least one additional US scan after 24 weeks and at least one week after first US",
            "startOffset": 43552,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 50272,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                },
                {
                    "id": "s0060",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0065",
            "sentence": "Case/study participant identifiers (e.g., medical record number) or code (or in accordance with country-specific data protection laws).",
            "startOffset": 50137,
            "title": "Demographics"
        },
        {
            "endOffset": 22651,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Genetic causes consist of rare inherited autosomal recessive conditions (primary autosomal recessive microcephaly) and syndromes resulting in defects in DNA repair or neuronal migration and disorders of telencephalic cleavage [23,24].",
            "startOffset": 22417,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35394,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Utilization of appropriate HC reference charts is recommended (see Appendix A) such as WHO Child Growth Standards [57] and Intergrowth 21st charts [58].",
            "startOffset": 35242,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 55293,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Physical and developmental outcome8 at last observation for living infants.",
            "startOffset": 54386,
            "title": "The adverse event"
        },
        {
            "endOffset": 52577,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "The composition and volume of the diluent used as well as information about whether the diluent was from the same or a separate container should also be recorded (lot number recorded if separate container).",
            "startOffset": 52371,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 52914,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0075",
            "sentence": "Needle length and gauge.",
            "startOffset": 52890,
            "title": "Details of the immunisation"
        },
        {
            "endOffset": 35188,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Flexible, non-stretchable, plastic or disposable paper",
            "startOffset": 35134,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 41193,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Level 3A of diagnostic certainty",
            "startOffset": 41161,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 37028,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "If after the first trimester, gestational age has not yet been confirmed and congenital microcephaly is suspected, HC should not be used to determine gestational age [60].",
            "startOffset": 36857,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 23305,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "While these reports do not document an association between vaccination in pregnancy and increased rates of congenital anomalies, some studies are limited by small sample sizes and lack of standardized definitions for outcomes makes it difficult to compare studies.",
            "startOffset": 23041,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35209,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "1\u20132 cm (1/4\u20131/2 in.)",
            "startOffset": 35189,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 64436,
            "parents": [],
            "secId": "s0100",
            "sentence": "They do not necessarily represent the official positions of each participant\u2019s organisation (e.g., government, university, or corporation).",
            "startOffset": 64297,
            "title": "Disclaimer"
        },
        {
            "endOffset": 27302,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "Multiple general medical, pediatric and infectious disease textbooks were included in the search criteria.",
            "startOffset": 27196,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 33774,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Congenital Microcephaly is a clinical syndrome based on head circumference (HC) measurements.",
            "startOffset": 33681,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 34428,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "The use of a metal tape measure is discouraged due to the risk of inadvertent laceration of the newborn\u2019s skin.",
            "startOffset": 34317,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 34526,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Whichever tape measure is used, the metric system should be used and marked by 0.1 cm increments.",
            "startOffset": 34429,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 41649,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Measured up to 6 weeks after birth or end of pregnancy with no apparent post-natal insult resulting in microcephaly",
            "startOffset": 41534,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 30491,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Laboratory findings are not included in the case definition.",
            "startOffset": 30431,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 45816,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "HC 2 SD below mean or <3 percentile according to fetal US scan using appropriate standardized reference charts according to GA and gender for the population (e.g., WHO growth reference charts if GA \u2a7e37 weeks and Intergrowth-21st reference charts for GA 24\u201336 weeks) with femur length and abdominal circumference concordant with GA assessment",
            "startOffset": 45475,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 18022,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "In addition to congenital microcephaly, there is also an acquired form of microcephaly in which an infant\u2019s head circumference falls within the normal range at birth with subsequent development of microcephaly over time due to deceleration of brain growth.",
            "startOffset": 17766,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 63013,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "It is essential to specify:",
            "startOffset": 62986,
            "title": "Data presentation"
        },
        {
            "endOffset": 29044,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Thus, a clinically very severe event may appropriately be classified as Level Two or Three rather than Level One if there is a lack of diagnostic criteria.",
            "startOffset": 28889,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 60735,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Data on congenital microcephaly obtained from subjects receiving a vaccine should be compared with those obtained from an appropriately selected and documented control group(s) to assess background rates in non-exposed populations, and should be analysed by study arm and dose where possible, e.g., in prospective clinical trials.",
            "startOffset": 60405,
            "title": "Data analysis"
        },
        {
            "endOffset": 50580,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                },
                {
                    "id": "s0060",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0065",
            "sentence": "Date of birth, gestional age at time of stillbirth, or gestational age at time of spontaneous or therapeutic abortion, if applicable estimated gestational age at time of fetal demise, age of mother, age of infant or gestational age of fetus, race and ethnicity of both infant and mother, and sex of fetus.",
            "startOffset": 50275,
            "title": "Demographics"
        },
        {
            "endOffset": 54382,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Treatment, if any given for congenital microcephaly and any associated conditions.",
            "startOffset": 54300,
            "title": "The adverse event"
        },
        {
            "endOffset": 62126,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "Data should be presented with numerator and denominator (n/N) (and not only in percentages), if available.",
            "startOffset": 62020,
            "title": "Data presentation"
        },
        {
            "endOffset": 26459,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "mp.",
            "startOffset": 26456,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 62761,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "If the distribution of data is skewed, median and range are usually the more appropriate statistical descriptors than a mean.",
            "startOffset": 62636,
            "title": "Data presentation"
        },
        {
            "endOffset": 23555,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "No cases of congenital microcephaly were reported to the Vaccine Adverse Event Reporting System following maternal immunisation with the tetanus, diphtheria and acellular pertussis vaccine (Tdap) during pregnancy for the time from 2011 to 2015 [52].",
            "startOffset": 23306,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 45470,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Fetus of at least 24 weeks GA based on certain or uncertain LMP with fundal height and no confirmatory 1st or 2nd trimester US scan",
            "startOffset": 45339,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 26112,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "mp.",
            "startOffset": 26109,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 18766,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "This constellation may be associated with a better intellectual prognosis than \u201cabsolute microcephaly\u201d or congenital microcephaly, in which weight and length are normal for gestational age and sex [4].",
            "startOffset": 18565,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 46273,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Fetus of at least 24 weeks GA based on certain LMP with confirmatory 1st trimester or 2nd trimester US scan, uncertain LMP with 2nd trimester US, IUI, embryo transfer date, or certain or uncertain LMP with fundal height and no confirmatory 1st or 2nd trimester US scan",
            "startOffset": 46005,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 38420,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "It should be noted that while all levels may be used in any setting, it is most likely that level 1 and 2 definitions for postnatally diagnosed congenital microcephaly will be primarily used in high resource settings with access to prenatal ultrasound.",
            "startOffset": 38168,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 41021,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Measured >36 h and up to 6 weeks after birth or end of pregnancy with no apparent post-natal insult resulting in microcephaly",
            "startOffset": 40896,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 34316,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "We recommend using a disposable paper tape measure or a plastic tape measure in which one end inserts into the other.",
            "startOffset": 34199,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 45972,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "No additional data to confirm microcephaly (i.e., No additional prenatal US scan or confirmation of microcephaly by HC measurement at birth or autopsy)",
            "startOffset": 45821,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 31592,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Further, congenital microcephaly often occurs outside the controlled setting of a clinical trial or hospital.",
            "startOffset": 31483,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 20448,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "A systematic review of 9 studies from India indicate a pooled prevalence rate of newborns with congenital microcephaly of 2.3 per 10,000 births (95% confidence interval [CI] 1.82\u20132.78) among 97,155 births [12].",
            "startOffset": 20238,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 62289,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "Although immunisation safety surveillance systems denominator data are usually not readily available, attempts should be made to identify approximate denominators.",
            "startOffset": 62126,
            "title": "Data presentation"
        },
        {
            "endOffset": 26958,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "We also reviewed additional publications related to the field.",
            "startOffset": 26896,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 34002,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Prenatally diagnosed (in utero) congenital microcephaly",
            "startOffset": 33947,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 36192,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Obtaining a cross-sectional view of the fetal head at the level of the thalami.",
            "startOffset": 36113,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 61638,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "All reported events of congenital microcephaly should be presented according to the categories listed in guideline 30.",
            "startOffset": 61520,
            "title": "Data presentation"
        },
        {
            "endOffset": 43815,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Confirmation of microcephaly by HC measurement with standard tape measure at birth or autopsy",
            "startOffset": 43722,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 44595,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Confirmation of microcephaly by HC measurement with standard tape measure at birth or autopsy",
            "startOffset": 44502,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 45305,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "No additional data to confirm microcephaly (i.e., No additional prenatal US scan or confirmation of microcephaly by HC measurement at birth or autopsy)",
            "startOffset": 45154,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 63453,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "The characteristics of the surveillance system (e.g., population served, mode of report solicitation);",
            "startOffset": 63351,
            "title": "Data presentation"
        },
        {
            "endOffset": 26340,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "sh,kw.",
            "startOffset": 26334,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 29172,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Detailed information about the severity of the event should always be recorded, as specified by the data collection guidelines.",
            "startOffset": 29045,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 49141,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0050",
            "sentence": "The additional guidelines have been developed as guidance for the collection of information to allow for a more comprehensive understanding of congenital microcephaly following maternal immunisation.",
            "startOffset": 48942,
            "title": "Data collection"
        },
        {
            "endOffset": 62518,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "The source of the denominator data should be reported and calculations of estimates be described (e.g., manufacturer data like total doses distributed, reporting through Ministry of Health, coverage/population based data, etc.).",
            "startOffset": 62290,
            "title": "Data presentation"
        },
        {
            "endOffset": 20122,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "While a series of 360 births with congenital microcephaly in Missouri, United States in the 1990s suggested a population incidence of more than 7 cases per 10,000 births [10], more recent data estimate congenital microcephaly rates from 2 to 12 cases per 10,000 livebirths [11].",
            "startOffset": 19844,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 27926,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "In some high resource settings, microcephaly may be diagnosed prenatally through ultrasound or other advanced imaging.",
            "startOffset": 27808,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 51741,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                },
                {
                    "id": "s0060",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0070",
            "sentence": "Use of prenatal vitamins and folic acid should also be noted.",
            "startOffset": 51680,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 54296,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Results of laboratory examinations (e.g., congenital syphilis, toxoplasmosis, Zika virus infection, other congenital infections) including genetic testing, surgical and/or pathological findings and diagnoses if present (e.g., results of amniocentesis).",
            "startOffset": 54044,
            "title": "The adverse event"
        },
        {
            "endOffset": 44500,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Confirmation of microcephaly (i.e., HC 2 SD below mean or <3 percentile) in fetus with at least one additional US scan after 24 weeks and at least one week after first US",
            "startOffset": 44330,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 40521,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Level 2B of diagnostic certainty",
            "startOffset": 40489,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 51679,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                },
                {
                    "id": "s0060",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0070",
            "sentence": "Also, for the mother, any medication history (other than treatment for the event described) prior to, during, and after immunisation including prescription and non-prescription medication a specific focus on potentially teratogenic medication exposures.",
            "startOffset": 51426,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 45149,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "HC 2 SD below mean or <3 percentile according to fetal US scan using appropriate standardized reference charts according to GA and gender for the population (e.g., WHO growth reference charts if GA \u2a7e37 weeks and Intergrowth-21st reference charts for GA 24\u201336 weeks) with femur length and abdominal circumference concordant with GA assessment",
            "startOffset": 44808,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 29885,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "As noted above, congenital microcephaly may exist alone, in the presence of other congenital anomalies, or as part of a syndrome.",
            "startOffset": 29756,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 33945,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Postnatally diagnosed (after birth) congenital microcephaly",
            "startOffset": 33886,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 36389,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Ensure that the skull is oval, symmetrical and visible all the way around on the ultrasound monitor.",
            "startOffset": 36289,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 26688,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "All abstracts were screened for possible reports of congenital microcephaly following maternal immunisation.",
            "startOffset": 26580,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 35091,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Therefore, it is important to repeat the measurement three times and to select the largest measurement to the nearest 0.1 cm [56] (see Fig. 2).",
            "startOffset": 34948,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 35838,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "A fetal HC measurement can be obtained starting at approximately 14 weeks estimated gestational age.",
            "startOffset": 35738,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 43979,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Fetus of at least 24 weeks GA based on certain or uncertain LMP with fundal height and no confirmatory 1st or 2nd trimester US scan",
            "startOffset": 43848,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 53960,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0080",
            "sentence": "Values and units of routinely measured parameters (e.g., cm, inches);",
            "startOffset": 53891,
            "title": "The adverse event"
        },
        {
            "endOffset": 62827,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "However, the mean and standard deviation should also be provided.",
            "startOffset": 62762,
            "title": "Data presentation"
        },
        {
            "endOffset": 60401,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "When only a small number of cases is presented, the respective values or time course can be presented individually.",
            "startOffset": 60286,
            "title": "Data analysis"
        },
        {
            "endOffset": 40369,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Measured >36 h and up to 6 weeks after birth or end of pregnancy with no apparent post-natal insult resulting in microcephaly",
            "startOffset": 40244,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 40613,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Live birth, stillbirth, or spontaneous or therapeutic abortion of at least 24 weeks of GA\u223c",
            "startOffset": 40523,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 64296,
            "parents": [],
            "secId": "s0100",
            "sentence": "The findings, opinions and assertions contained in this consensus document are those of the individual scientific professional members of the working group.",
            "startOffset": 64140,
            "title": "Disclaimer"
        },
        {
            "endOffset": 30858,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "The meaning of \u201csudden onset\u201d and \u201crapid progression\u201d in the context of congenital microcephaly is not applicable as this condition is present at birth or at the time of fetal demise.",
            "startOffset": 30675,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 37167,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "In cases of congenital microcephaly, intracranial anatomy may be distorted and other associated intracranial findings may be present [61].",
            "startOffset": 37029,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 24273,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "As previously discussed, maternal immunisation has not been associated with congenital microcephaly in offspring.",
            "startOffset": 24160,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 41718,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "\u223cGA based on LMP without confirmatory 1st or 2nd trimester ultrasound",
            "startOffset": 41649,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 28743,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "They instead reflect diagnostic certainty (see below).",
            "startOffset": 28689,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 51260,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                },
                {
                    "id": "s0060",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0070",
            "sentence": "For the mother, pre-conception medical history, including hospitalisations, underlying diseases/disorders, and medications as well as medical history during pregnancy such as exposure to substances related to congenital microcephaly, tobacco use, alcohol use, illicit drug use, pre-immunisation signs and symptoms including identification of indicators for, or the absence of, a history of allergy to vaccines, vaccine components or medications.",
            "startOffset": 50815,
            "title": "Clinical and immunisation history"
        },
        {
            "endOffset": 58636,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Level 3: Criteria as specified in the congenital microcephaly case definition",
            "startOffset": 58559,
            "title": "Data analysis"
        },
        {
            "endOffset": 22172,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "These in utero exposures along with postnatal brain injury due to infections, infarction or trauma represent the most common known causes of microcephaly.",
            "startOffset": 22018,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 39961,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Live birth, stillbirth, or spontaneous or therapeutic abortion of at least 24 weeks of GA\u223c",
            "startOffset": 39871,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 42378,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Diagnosis of congenital microcephaly based on ICD-9-CM or ICD-10-CM code that does not meet validated algorithm criteria above.",
            "startOffset": 42251,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 62985,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "Any publication of data on congenital microcephaly should include a detailed description of the methods used for data collection and analysis as possible.",
            "startOffset": 62831,
            "title": "Data presentation"
        },
        {
            "endOffset": 24473,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The goal of developing this guideline is to improve and standardize data collection and interpretation in order to evaluate for associations between maternal immunisation and congenital microcephaly.",
            "startOffset": 24274,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 25015,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The case definitions and guidelines are intended to be applicable in diverse geographic, administrative, and cultural regions, adaptable to both high and low resource settings.",
            "startOffset": 24839,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26145,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "OR (immunisation\u2217 and pregnan\u2217).",
            "startOffset": 26113,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 37617,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "There are currently several fetal growth standards in use for head circumference measurements including those from the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project, the WHO Multicentre Growth Reference Study (MGRS), the National Institute of Child Health and Human Development (NICHD) Fetal Growth Studies, and those referenced by the United States Society for Maternal-Fetal Medicine (SMFM) based on Hadlock growth curves [61\u201364].",
            "startOffset": 37167,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 50666,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                },
                {
                    "id": "s0060",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0065",
            "sentence": "For infants: Gestational age and birth weight, birth length and head circumference.",
            "startOffset": 50583,
            "title": "Demographics"
        },
        {
            "endOffset": 57505,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "The following guidelines represent a desirable standard for analysis of data on congenital microcephaly to allow for comparability of data, and are recommended as an addition to data analysed for the specific study question and setting.",
            "startOffset": 57269,
            "title": "Data analysis"
        },
        {
            "endOffset": 40242,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Measured within the first 24 h \u00a7",
            "startOffset": 40210,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 33224,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0025",
            "sentence": "Both were developed to improve data comparability.",
            "startOffset": 33174,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 62632,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "The incidence of cases in the study population should be presented and clearly identified as such in the text.",
            "startOffset": 62522,
            "title": "Data presentation"
        },
        {
            "endOffset": 21620,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Any condition that affects the process of brain growth can result in microcephaly [21].",
            "startOffset": 21533,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 30431,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "We have also included radiology findings, specifically fetal ultrasound examination results, for use in the prenatal definition for congenital microcephaly.",
            "startOffset": 30275,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 30100,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "It is possible that congenital microcephaly may be related to or discovered after spontaneous abortion, stillbirth or an elective therapeutic abortion, and thus data collection should not be limited to live births.",
            "startOffset": 29886,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 30274,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Thus, pathology findings of head circumference measurement performed during autopsy of stillbirth or spontaneous or therapeutic abortion are included in the case definition.",
            "startOffset": 30101,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 36856,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Ideally, dating is based on or confirmed by a first trimester ultrasound scan using crown-rump length for measurement.",
            "startOffset": 36738,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 21003,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Another review from North Eastern Brazil employing three different criteria showed markedly varying rates [14].",
            "startOffset": 20892,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 26579,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0015",
            "sentence": "The search resulted in the identification of 23 references written in English.",
            "startOffset": 26501,
            "title": "Methods for the development of the case definition and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 21532,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "The causes of congenital microcephaly are extensive, highly variable and heterogeneous, and include both known and undetermined aetiologies.",
            "startOffset": 21392,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 37774,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "The head circumference measurements of the Intergrowth 21st Project with its international standards is the most applicable to multinational vaccine trials.",
            "startOffset": 37618,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 44803,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Fetus of at least 24 weeks GA based on certain LMP with confirmatory 1st trimester or 2nd trimester US scan, uncertain LMP with 2nd trimester US, IUI, or embryo transfer date",
            "startOffset": 44629,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 41161,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "\u00a7Take into account the variability in this period based on molding of the head",
            "startOffset": 41083,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 42156,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Live birth, stillbirth, or spontaneous or therapeutic abortion",
            "startOffset": 42094,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 49479,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                }
            ],
            "secId": "s0055",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 49373,
            "title": "Source of information/reporter"
        },
        {
            "endOffset": 63500,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "The search strategy in surveillance databases;",
            "startOffset": 63454,
            "title": "Data presentation"
        },
        {
            "endOffset": 30948,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "We also do not include specific time frames for onset of symptoms following immunisation.",
            "startOffset": 30859,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 50134,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                },
                {
                    "id": "s0050",
                    "title": "Data collection"
                },
                {
                    "id": "s0060",
                    "title": "Vaccinee/control"
                }
            ],
            "secId": "s0065",
            "sentence": "For all cases and/or all study participants, as appropriate, the following information should be recorded:",
            "startOffset": 50028,
            "title": "Demographics"
        },
        {
            "endOffset": 59322,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "In addition, congenital microcephaly attributed to an alternative cause (e.g., congenital CMV) should still be recorded and identified as likely attributable to a known cause.",
            "startOffset": 59147,
            "title": "Data analysis"
        },
        {
            "endOffset": 61516,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "Additionally, it is recommended to refer to existing general guidelines for the presentation and publication of randomised controlled trials, systematic reviews, and meta-analyses of observational studies in epidemiology (e.g. statements of Consolidated Standards of Reporting Trials (CONSORT), of Improving the quality of reports of meta-analyses of randomised controlled trials (QUORUM), and of meta-analysis Of Observational Studies in Epidemiology (MOOSE), respectively).",
            "startOffset": 61041,
            "title": "Data presentation"
        },
        {
            "endOffset": 36614,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "Intracranial anatomy should be visible with centrally positioned continuous medline echo (falx cerebri) broken anteriorly by the cavum septum pellucidum and with the thalami visible symmetrically on each side of the midline.",
            "startOffset": 36390,
            "title": "For all levels of diagnostic certainty"
        },
        {
            "endOffset": 60085,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0090",
            "sentence": "Analysis may also include other characteristics like qualitative patterns of criteria defining the event.",
            "startOffset": 59980,
            "title": "Data analysis"
        },
        {
            "endOffset": 63109,
            "parents": [
                {
                    "id": "s0045",
                    "title": "Guidelines for data collection, analysis and presentation of congenital microcephaly"
                }
            ],
            "secId": "s0095",
            "sentence": "The method, frequency and duration of monitoring for congenital microcephaly;",
            "startOffset": 63032,
            "title": "Data presentation"
        },
        {
            "endOffset": 18273,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0010",
            "sentence": "Classifying microcephaly as either congenital or acquired is the currently favored nomenclature rather than the past designations of \u201cprimary,\u201d \u201cpure,\u201d or \u201ctrue\u201d for congenital microcephaly versus \u201csecondary\u201d or \u201csyndromic\u201d for acquired microcephaly.",
            "startOffset": 18023,
            "title": "Need for developing case definitions and guidelines for data collection, analysis, and presentation for congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 33173,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0025",
            "sentence": "Neither case definition nor guidelines are intended to guide or establish criteria for management of ill infants, children, or adults.",
            "startOffset": 33039,
            "title": "Guidelines for data collection, analysis and presentation"
        },
        {
            "endOffset": 28351,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Preamble"
                }
            ],
            "secId": "s0020",
            "sentence": "Thus, congenital microcephaly can be classified as diagnosed \u201cpostnatally\u201d or \u201cprenatally\u201d, based exclusively on the timing of when the diagnosis of microcephaly is made [5].",
            "startOffset": 28177,
            "title": "Rationale for selected decisions about the case definition of congenital microcephaly as an adverse event following maternal immunisation"
        },
        {
            "endOffset": 36288,
            "parents": [
                {
                    "id": "s0035",
                    "title": "Case definition of congenital microcephaly3The case definition should be applied when there is no clear alternative diagnosis for the reported event to account for the combination of symptoms.3"
                }
            ],
            "secId": "s0040",
            "sentence": "The cross-section view of the fetal head should take up at least 30% of the ultrasound monitor.",
            "startOffset": 36193,
            "title": "For all levels of diagnostic certainty"
        }
    ],
    "docId": "S0264410X1730107X",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Malini",
                "initial": "M.",
                "last": "DeSilva"
            },
            {
                "email": null,
                "first": "Flor M.",
                "initial": "F.M.",
                "last": "Munoz"
            },
            {
                "email": null,
                "first": "Erick",
                "initial": "E.",
                "last": "Sell"
            },
            {
                "email": null,
                "first": "Helen",
                "initial": "H.",
                "last": "Marshall"
            },
            {
                "email": null,
                "first": "Alison",
                "initial": "A.",
                "last": "Tse Kawai"
            },
            {
                "email": null,
                "first": "Alisa",
                "initial": "A.",
                "last": "Kachikis"
            },
            {
                "email": null,
                "first": "Paul",
                "initial": "P.",
                "last": "Heath"
            },
            {
                "email": null,
                "first": "Nicola P.",
                "initial": "N.P.",
                "last": "Klein"
            },
            {
                "email": null,
                "first": "James M.",
                "initial": "J.M.",
                "last": "Oleske"
            },
            {
                "email": null,
                "first": "Fyezah",
                "initial": "F.",
                "last": "Jehan"
            },
            {
                "email": null,
                "first": "Hans",
                "initial": "H.",
                "last": "Spiegel"
            },
            {
                "email": null,
                "first": "Mirjana",
                "initial": "M.",
                "last": "Nesin"
            },
            {
                "email": null,
                "first": "Beckie N.",
                "initial": "B.N.",
                "last": "Tagbo"
            },
            {
                "email": null,
                "first": "Anju",
                "initial": "A.",
                "last": "Shrestha"
            },
            {
                "email": null,
                "first": "Clare L.",
                "initial": "C.L.",
                "last": "Cutland"
            },
            {
                "email": null,
                "first": "Linda O.",
                "initial": "L.O.",
                "last": "Eckert"
            },
            {
                "email": null,
                "first": "Sonali",
                "initial": "S.",
                "last": "Kochhar"
            },
            {
                "email": "contact@brightoncollaboration.org",
                "first": "Azucena",
                "initial": "A.",
                "last": "Bardaj\u00ed"
            },
            {
                "email": null,
                "first": null,
                "initial": null,
                "last": null
            }
        ],
        "doi": "10.1016/j.vaccine.2017.01.044",
        "firstpage": "6472",
        "issn": "0264410X",
        "keywords": [
            "Adverse event",
            "Brighton Collaboration",
            "Case definition",
            "Congenital microcephaly",
            "GAIA",
            "Guidelines",
            "Immunisation"
        ],
        "lastpage": "6482",
        "openaccess": "Full",
        "pub_year": 2017,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Congenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation"
    }
}